Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital, University of Barcelona, Barcelona, Spain.
Transplant Medicine Unit, San Raffaele Hospital, Milan, Italy.
Transpl Infect Dis. 2021 Apr;23(2):e13495. doi: 10.1111/tid.13495. Epub 2020 Nov 3.
Differential diagnosis between Polyoma virus associated-nephropathy (PVAN) and T-cell mediated rejection (TCMR) might be challenging, as respective treatment approaches are totally opposite. Here we report the illustrative case of a kidney transplant recipient with PVAN who developed a persistent acute TCMR after full abrogation of viral infection through immunosuppression modulation. By simultaneous functional immune monitoring of BKV and donor-specific T-cell responses using IFN-γELISPOT assay, we retrospectively demonstrated the predominant effector mechanisms responsible of allograft injury and thus, potential guidance for treatment decision-making. Furthermore, the evidence of an efficient T-cell alloimmunity abrogation accompanied by a sustained anti-viral response after sirolimus addition, promotes the potential benefit of converting patients to an mTOR-based immunosuppression in case of PVAN.
巨细胞病毒相关性肾病(PVAN)与 T 细胞介导的排斥反应(TCMR)之间的鉴别诊断可能具有挑战性,因为各自的治疗方法完全相反。在这里,我们报告了一例 PVAN 肾移植受者的病例,在通过免疫抑制调节完全消除病毒感染后,该患者发生了持续的急性 TCMR。通过使用 IFN-γ ELISPOT assay 同时进行 BKV 和供体特异性 T 细胞反应的功能免疫监测,我们回顾性地证明了导致同种异体移植物损伤的主要效应机制,从而为治疗决策提供了潜在的指导。此外,在添加西罗莫司后,观察到有效的 T 细胞同种免疫消除以及持续的抗病毒反应,这表明在发生 PVAN 的情况下,将患者转换为基于 mTOR 的免疫抑制可能具有潜在益处。